Mary Coelho
Directeur Financier/CFO chez GAMIDA CELL LTD.
Fortune : 55 388 $ au 30/04/2024
Profil
Mary Theresa Coelho is currently an Independent Director at Inotiv, Inc., First Wave Biopharma, Inc., HOOKIPA Pharma, Inc., and Gamida Cell Ltd.
She is also the Chief Financial & Accounting Officer at Gamida Cell Ltd.
In the past, she held positions such as Chief Financial Officer & Treasurer at Balchem Corp., Chief Financial Officer, Treasurer & Executive VP at BioDelivery Sciences International, Inc., Chief Operating Officer at Diversey, Inc., and Global Head-Oncology Development Finance at Mars, Inc. and Novartis Pharmaceuticals Corp.
She was also the Chief Financial & Business Development Officer at CinCor Pharma, Inc. Ms. Coelho holds an MBA from Ibmec Business School and an undergraduate degree from the School of International Service.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INOTIV, INC.
0,05% | 17/10/2023 | 12 911 ( 0,05% ) | 55 388 $ | 30/04/2024 |
GAMIDA CELL LTD.
-.--% | 12/06/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Mary Coelho
| Sociétés | Poste | Début |
|---|---|---|
| FIRST WAVE BIOPHARMA, INC. | Directeur/Membre du Conseil | 11/08/2021 |
| HOOKIPA PHARMA INC. | Directeur/Membre du Conseil | 03/04/2023 |
| GAMIDA CELL LTD. | Directeur Financier/CFO | 22/05/2023 |
| INOTIV, INC. | Directeur/Membre du Conseil | 16/10/2023 |
Anciens postes connus de Mary Coelho
| Sociétés | Poste | Fin |
|---|---|---|
| CINCOR PHARMA, INC. | Directeur Financier/CFO | 04/11/2022 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Directeur Financier/CFO | 03/11/2021 |
| BALCHEM CORPORATION | Directeur Financier/CFO | 26/10/2018 |
Diversey, Inc.
 Diversey, Inc. Household/Personal CareConsumer Non-Durables Diversey, Inc. engages in the provision of cleaning, sanitation, and maintenance products, systems, and services. The firm offers floor care, dilution control, kitchen care, infection prevention, fabric care, food and beverage production, building care, and personal care. The company was founded by August Koch and Herbert W. Kochs on August 4, 1923 and is headquartered in Fort Mill, NC. | Directeur Financier/CFO | 01/09/2017 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/10/2014 |
Formation de Mary Coelho
| School of International Service | Undergraduate Degree |
| Ibmec Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| BALCHEM CORPORATION | Consumer Non-Durables |
| FIRST WAVE BIOPHARMA, INC. | Health Technology |
| HOOKIPA PHARMA INC. | Health Technology |
| GAMIDA CELL LTD. | Health Technology |
| INOTIV, INC. | Commercial Services |
| Entreprise privées | 5 |
|---|---|
Diversey, Inc.
Diversey, Inc. Household/Personal CareConsumer Non-Durables Diversey, Inc. engages in the provision of cleaning, sanitation, and maintenance products, systems, and services. The firm offers floor care, dilution control, kitchen care, infection prevention, fabric care, food and beverage production, building care, and personal care. The company was founded by August Koch and Herbert W. Kochs on August 4, 1923 and is headquartered in Fort Mill, NC. | Consumer Non-Durables |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Mars, Inc.
 Mars, Inc. Food: Specialty/CandyConsumer Non-Durables Mars, Inc. engages in the production of confectionery and animal food products. Its brands include M&M?s, Snickers, Twix, Milky Way, Dove, Pedigree, Whiskas, Extra, Skittles, Uncle Ben's, and Cocoavia. The company was founded by Franklin Clarence Mars in 1911 and is headquartered in McLean, VA. | Consumer Non-Durables |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
